NCT05770141 is a NA clinical trial of laser hemorrhoidoplasty in Hemorrhoids, sponsored by Assiut University.

Who is sponsoring NCT05770141?

NCT05770141 is sponsored by Assiut University.

What drugs are being tested in NCT05770141?

Interventions in NCT05770141: laser hemorrhoidoplasty, open surgical hemorrhoidectomy.

What condition does NCT05770141 study?

NCT05770141 studies Hemorrhoids.

Is NCT05770141 still recruiting?

NCT05770141 is currently status unknown. Last updated 15 March 2023.

Last reviewed 2023-03-15 · How we verify

NCT05770141

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Laser Hemorrhoidoplasty Versus Open Surgical Hemorrhoidectomy in Second and Third Degree Piles

Status unknown NA Last updated 15 March 2023

What this trial tests

NA trial testing laser hemorrhoidoplasty in Hemorrhoids in 40 participants. Status unknown.

Timeline

1 April 2023

Primary endpoint
1 February 2025

1 March 2025

Quick facts

Lead sponsor	Assiut University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	40
Start date	1 April 2023
Primary completion	1 February 2025
Estimated completion	1 March 2025

Drugs / interventions tested

laser hemorrhoidoplasty
open surgical hemorrhoidectomy

Conditions studied

Hemorrhoids — all drugs for Hemorrhoids →

Sponsor

Assiut University

Who can join

16 and older, any sex, with Hemorrhoids. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to compare the pain , duration of intervention and long term outcomes of laser hemorrhoidoplasty versus open surgical hemorrhoidectomy

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hemorrhoids

Currently open trials in the same condition.

NCT07350460 — PUSHES (Pudendal Block Versus Sacral ESP Hemorrhoidectomy Study) · NA · recruiting
NCT07317492 — HEMOVAR Study on Hemorrhoids and Varicose Veins · recruiting
NCT05782010 — SCI-Pex Study - Safety and Performance of PexyEazy®, a Device for Treatment of Hemorrhoids · NA · recruiting
NCT05697562 — Evaluation of Superior Rectal Arterial Embolization in Hemorrhoidal Disease · NA · recruiting
NCT03972956 — Samples Procurement for Colorectal Cancer, Gastric Cancer, and Non-malignant Disease · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05770141 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 15 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05770141.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing